Ezra Maguen

Alterations of corneal extracellular matrix after multiple refractive procedures: a clinical and immunohistochemical study.

PURPOSE To describe the clinical course and alterations of the corneal extracellular matrix (ECM) and basement membrane (BM) in a cornea after hexagonal keratotomy, transverse keratotomies, and keratomileusis. METHODS Frozen sections of this cornea and of 12 normal corneas were studied by immunofluorescence with specific antibodies. The patient history was analyzed to allow a clinical correlation. RESULTS In the treated cornea, keratotomy scars and subepithelial fibrosis with neovascularization were seen. Around and beneath the epithelial plugs and along the keratotomy scars, deposits of types III, VI, VIII, and XIV collagen; fibrillin-1; fibronectin; and tenascin-C were found, together with short streaks of types IV (alpha 1-alpha 2) and VII collagen, laminin-1 and -5, entactin, and perlecan. alpha 3-alpha 4 Type IV collagen chains were abnormally absent from the BM around the epithelial plugs. At the edges of the keratomileusis flap, subepithelial fibrosis areas were found, with abnormal deposits of eight different collagen types, perlecan, fibronectin, fibrillin-1, and tenascin-C. The major part of the flap interface did not show ECM abnormalities. ECM alterations outside the scarred areas included the appearance of tenascin-C in the stroma and of alpha 1-alpha 2 type IV collagen in the epithelial BM, and the disappearance of fibronectin from Descemets membrane. CONCLUSION Five years after surgery, the treated cornea still presented BM abnormalities at sites of keratotomy scars and epithelial plugs. Several ECM components were abnormally expressed outside the scarred areas, consistent with an ongoing fibrosis in the treated cornea.

Preliminary results of tracked laser-assisted in-situ keratomileusis (T-LASIK) for myopia and hyperopia using the autonomous technologies excimer laser system

A study was undertaken to assess the safety and efficacy of LASIK with the LADARVision laser by Autonomous Technologies, (Orlando, FL). The study included four subsets: Spherical myopia -- up to -11.00D, spherical hyperopia -- up to +6.00D. Both myopic and hyperopic astigmatism could be corrected, up to 6.00D of astigmatism. A total of 105 patients participated. Sixty-six patients were myopic and 39 were hyperopic. The mean (+/- SD) age was 42.8 +/- 9.3 years for myopia and 53.2 +/- 9.9 years for hyperopia. At 3 months postop. Sixty-one myopic eyes were available for evaluation. Uncorrected visual acuity was 20/20 in 70% of eyes and 20/40 in 92.9% of all eyes. The refractive outcome was within +/- 0.50D in 73.8% of eyes and within +/- 1.00D in 96.7 of eyes. Thirty-eight hyperopic eyes were available. Uncorrected visual acuity was 20/20 in 42.1% of eyes and 20/40 in 88% of all eyes. The refractive outcome was within +/- 0.50D in 57.9% of eyes and within +/- 1.00D in 86.8% of eyes. Complications were not sight threatening and were discussed in detail. Lasik with the LADARVision laser appears to be safe and effective.

Preliminary results of tracked photorefractive keratectomy (T-PRK) for mild to moderate myopia with the autonomous technologies excimer laser at Cedars-Sinai Medical Center

Preliminary results of the correction of myopia up to -7.00 D by tracked photorefractive keratectomy (T-PRK) with a scanning and tracking excimer laser by Autonomous Technologies are discussed. 41 eyes participated (20 males). 28 eyes were evaluated one month postop. At epithelization day mean uncorrected vision was 20/45.3. At one month postop, 92.8 of eyes were 20/40 and 46.4% were 20/20. No eye was worse than 20/50. 75% of eyes were within +/- 0.5 D of emmetropia and 82% were within +/- 1.00 D of emmetropia. Eyes corrected for monovision were included. One eye lost 3 lines of best corrected vision, and had more than 1.00 D induced astigmatism due to a central corneal ulcer. Additional complications included symptomatic recurrent corneal erosions which were controlled with topical hypertonic saline. T-PRK appears to allow effective correction of low to moderate myopia. Further study will establish safety and efficacy of the procedure.